24/02/2017 11:10:41

NeuroSearch A/S releasing Annual Report 2016

Related content
05 Dec - 
Update on NeuroSearch’s business status and future
17 Nov - 
NeuroSearch upgrades its guidance for 2017
31 Aug - 
NeuroSearch A/S – H1 report 2017
Related debate
14 May - 
Tror den skal i 1.80kr . Køb Genmab det er kvalitet
14 May - 
Jeg anbefalede den, den 17.04.2018 sent om aftenen. Dag..
14 May - 
Det har der vist været snak om i årevis.&nb..

Company announcement

24 February 2017

The full version of the Annual Report 2016 for NeuroSearch is available in the enclosed PDF file.

In 2016, the NeuroSearch Group (NEUR) posted an operating loss on continuing operations of DKK 6 million (2015: 7 million), which was on a level with the Company's previously announced expectations of an operating loss of DKK 4-6 million.

The Company posted a profit of DKK 1 million on discontinued operations (2015: DKK 1 million).

NeuroSearch posted an income after tax on continuing operations of DKK 22 million (2015: loss of DKK 7 million). The income for the year includes recycling of currency translation in the amount of DKK 23.5 million.

Consolidated profit was an income of DKK 23 million (2015: loss of DKK 6 million).

At the end of 2016, cash and cash equivalents totalled DKK 74 million (2015: DKK 78 million).

For a complete description of performance in the 2016 financial year, we refer to the Annual Report 2016 of NeuroSearch accompanying this announcement, and which is also available on our website as from today.

Outlook for 2017

In 2017, NeuroSearch expects an operating loss in the range of DKK 4.5-5.5 million. The outlook primarily includes costs for the continuing efforts to dispose of the Company’s assets, maintaining the Company’s stock exchange listing and maintaining its day-to-day operations. The outlook does not include any income from the possible sale of Company assets, other potential income from the Company's agreements with Teva, Saniona or others.

Karin Garre                                                                       Allan Andersen

Chairman                                                                          CEO

Contact

Allan Andersen, CEO, mobile +45 4016 3864.

About NeuroSearch

NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.

 

APPENDIX

Financial highlights for the NeuroSearch Group

 

(DKK millions)

 

2012

2013

2014

2015

2016

 

 

 

Income statement and comprehensive income

 

 

 

 

 

 

Gain from divestment of intellectual property

 

120.7

28.8

-

-

1.3

Development costs

 

457.2

21.7

-

-

-

General and administrative costs

 

(46.7)

16.7

13.3

6.5

7.6

Operating profit/(loss)

 

(289.8)

(9.6)

(13.3)

(6.5)

(6.3)

Net financials

 

(37.2)

5.1

2.7

(0.3)

27.9

Profit/(loss) of continuing operations before tax

 

(327.1)

(4.5)

(10.6)

(6.8)

21.6

Net profit/(loss) of discontinued operations

 

57.4

15.6

1.6

1.3

1.2

Profit/(loss) for the period

 

(275.6)

12.4

(7.7)

(5.5)

22.8

Comprehensive income**

 

(243.5)

6.6

(10.2)

(5.3)

(1.0)

 

 

 

 

 

 

Balance sheet

 

 

 

 

 

 

Total assets

 

207.5

92.2

84.0

78.6

79.4

Cash and cash equivalents and securities

 

81.4

88.8

83.4

78.0

74.4

Equity

 

81.1

88.0

77.7

72.4

71.4

 

 

 

 

 

 

 

Investments

 

 

 

 

 

 

Per share ratios* (DKK)

 

 

 

 

 

 

Earnings per share

 

(11.22)

0.50

(0.32)

(0.23)

0.93

Diluted earnings per share

 

(11.22)

0.50

(0.32)

(0.23)

0.93

Net asset value

 

3.30

3.58

3.17

2.95

2.91

Market price at year-end

 

3.74

3.10

2.59

2.51

3.01

Market price/net asset value

 

1.13

0.87

0.82

0.85

1.04

 

 

 

 

 

 

 

Average number of employees

 

88

18

2

2

2

Number of employees at 31 December

 

26

2

2

2

2

*     The ratios are stated in accordance with "Recommendations and Financial Ratios" issued by The Danish Finance Society.

**    Comprehensive income includes unrealised currency translation adjustment and fair value adjustment of the hedge of the net investment in NeuroSearch Sweden AB.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
WISeKey Partners with Highscreen International SA to Develop WISePhone - the First Ever Secure Blockchain Phone with Cryptocurrency Payment Capabilities
2
CLPS Incorporation Announces Pricing of $10.5 Million Firm Commitment Initial Public Offering
3
DNO Reports Payment for Tawke Deliveries
4
Arcturus Therapeutics Comments on Court Ruling on Undisclosed Group Organized by Joseph E. Payne and his Associates in Violation of Regulation 13D
5
Microchip Technology Incorporated Prices $2.0 Billion Note Offering

Related stock quotes

NeuroSearch A/S 4.000 -1.2% Stock price decreasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 May 2018 00:24:47
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180524.2 - EUROWEB3 - 2018-05-25 01:24:47 - 2018-05-25 00:24:47 - 1000 - Website: OKAY